indication for semaglutide FDA has approved a new, higher-dose 7.2 mg weekly injection of #Wegovy (# semaglutide) long-term weight management in adults with obesity or overweight. 🔹Indication: It is intended as a “step-up” therapy for Oral Wegovy approved for obesity

T2DM is a leading risk factor for PAD, which limits physical functions

These results suggest that semaglutide can be a valuable tool for those struggling with obesity or weight-related health issues

The risks for patients who received semaglutide relative to those who received dulaglutide for the outcome measures were estimated by calculating the crude hazard ratios (HRs) and their 95% confidence intervals (CIs)

High doses or risky combinations can make it permanent

Taking the Next Step If youve felt stuck between diet culture extremes and pharmaceutical fasttracks, the benefits of microdosing semaglutide offer a middle pathone that respects your hormones, mental health, and longterm goals